Z Ruszczak Selected Research

Interleukins

2/2021

Intermittent use of biologic agents for the treatment of psoriasis in adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Z Ruszczak Research Topics

Disease

1	Necrosis 02/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2021
1	Pressure Ulcer (Bedsore) 09/2006
1	Leg Ulcer 09/2006
1	Diabetic Foot 09/2006
1	Ulcer 09/2006
1	Wounds and Injuries (Trauma) 09/2006
1	Surgical Wound 09/2006
1	Burns 09/2006
1	Hidradenitis Suppurativa 05/2001

Drug/Important Bio-Agent (IBA)

1	guselkumabIBA 02/2021
1	ixekizumabIBA 02/2021
1	secukinumabIBA 02/2021
1	brodalumabIBA 02/2021
1	Certolizumab Pegol FDA Link 02/2021
1	Etanercept (Enbrel)FDA Link 02/2021
1	Adalimumab (Humira)FDA Link 02/2021
1	Infliximab (Remicade)FDA Link 02/2021
1	Ustekinumab (CNTO 1275)FDA Link 02/2021
1	InterleukinsIBA 02/2021
1	Interleukin-12 (IL 12)IBA 02/2021
1	Interleukin-17 (Interleukin 17)IBA 02/2021
1	Interleukin-23 (Interleukin 23)IBA 02/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2006
1	Immunoglobulin E (IgE)IBA 05/2001

Therapy/Procedure

1	Surgical Amputation (Amputations) 09/2006
1	Biological Dressings 09/2006